Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?


Drug Profile


Alternative Names: BIRR 0001; BIRR 1; Murine anti-CD54 monoclonal antibody; Murine anti-ICAM-1 monoclonal antibody; R6 5 D6; R6.5; RR1; RR1/1

Latest Information Update: 18 Dec 2001

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Boehringer Ingelheim
  • Class Monoclonal antibodies
  • Mechanism of Action Immunosuppressants; Intercellular adhesion molecule 1 antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Asthma; Autoimmune disorders; Burns; Diabetes mellitus; Graft-versus-host disease; Intracranial thrombosis; Liver transplant rejection; Myocardial ischaemia; Renal transplant rejection; Rheumatoid arthritis; Stroke

Most Recent Events

  • 18 Dec 2001 A study has been added to the adverse events and Neurological Disorders therapeutic trials sections
  • 10 May 1999 Results of a clinical study were added to the adverse events and therapeutic trials sections
  • 03 Feb 1999 A study has been added to the Neurological disorders pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top